oral semaglutide fda approval Approves as the First Oral GLP-1 Pill The FDA has officially approved
Description
Orforglipron pill $149.
It has the active ingredient semaglutide and is prescribed for patients with a high BMI (our clinicians will check your BMI before prescribing Wegovy)
Learn about the titration and dosage schedules for semaglutide

FDA-approved GLP-1 medication offering proven weight loss results

Lilly is on track to file its oral GLP-1 agonist orforglipron for type 2 diabetes next year after presenting the first phase 3 data with the drug.

Physician-supervised GLP-1 weight loss programs at Youtherapy MedSpa
